Catalysts
About Quantinuum
Quantinuum develops full stack quantum computing systems, software and applications for enterprise, government and research customers.
What are the underlying business or industry changes driving this perspective?
- Quantinuum is integrating quantum systems with AI and high performance computing through partners such as Oracle and HPE. This can deepen usage of Helios and future systems within existing data center and cloud workflows and support recurring revenue from cloud access and software over time.
- The company is positioned against increasing government focus on quantum as critical infrastructure, including the U.S. CHIPS R&D program and executive orders. This can support hardware deployment into national labs and agencies and help underpin visibility for future revenue streams.
- The hardware road map from Helios to Sol in 2027 and Apollo in 2029 is being derisked through intermediate milestones such as validated 2D QCCD trap chips and new error correction code families. This can help sustain premium system pricing and support long run gross margin targets above 50%.
- Expansion of the Nexus developer platform, including the Guppy language and growing usage by more than 180 organizations, can increase software and services adoption on top of existing hardware and support higher margin revenue mix over time.
- The CHIPS R&D letter of intent for up to US$100 million and joint development with a global electronics manufacturer support scaled manufacturing and a diversified supply chain. This can improve cost efficiency and help protect net margins as system volumes and complexity rise.
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Quantinuum's revenue will grow by 187.1% annually over the next 3 years.
- Analysts are not forecasting that Quantinuum will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Quantinuum's profit margin will increase from -1748.3% to the average US IT industry of 8.1% in 3 years.
- If Quantinuum's profit margin were to converge on the industry average, you could expect earnings to reach $32.8 million (and earnings per share of $0.11) by about August 2029, up from -$298.7 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 1178.1x on those 2029 earnings, up from -6.3x today. This future PE is greater than the current PE for the US IT industry at 18.7x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.22%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?
- Quantinuum is still in a heavy investment phase with a reported GAAP net loss of US$596.5 million in Q2 2026, an adjusted EBITDA loss of US$68 million and adjusted net loss of US$73 million, so any delay in scaling revenue while R&D, sales and public company costs remain high could pressure earnings and delay any path to profitability.
- The long-term road map depends on timely delivery of Sol in 2027 and Apollo in 2029, and management repeatedly acknowledges technical derisking still underway. Slippage in product timing or performance could slow customer adoption, reduce hardware orders and affect both revenue and gross margins.
- Current visibility leans on a large pipeline and bookings that management describes as in the billions of dollars with remaining performance obligations already around US$74 million, yet actual revenue guidance for 2026 is only US$28 million to US$32 million. If bookings convert to revenue more slowly than expected, the outcome could be lower near term revenue growth and weaker cash generation.
- The business model is in transition from lumpy system sales to a mix that includes more cloud, software and services, and management highlights expected volatility in quarterly results. If higher margin recurring revenue segments grow more slowly than planned, overall gross margin and net margins could remain under pressure for longer.
- Quantinuum relies on external partners and government programs, including an LOI with the U.S. CHIPS R&D Office for up to US$100 million and multiple manufacturing and cloud partners. Any change in government priorities, funding timing or partner commitment could raise capital needs and weigh on future revenue, gross margin and free cash flow.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $98.75 for Quantinuum based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $155.0, and the most bearish reporting a price target of just $78.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $404.1 million, earnings will come to $32.8 million, and it would be trading on a PE ratio of 1178.1x, assuming you use a discount rate of 9.2%.
- Given the current share price of $56.06, the analyst price target of $98.75 is 43.2% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Quantinuum?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.